Tag: Monoclonal antibody therapy
NHIA comments on physician fee schedule
September 1, 2022HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association has submitted comments on a CMS proposed rule that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste. While NHIA applauds the continued coverage for pre-exposure prophylaxis to COVID-19 with monoclonal antibodies beyond the public health emergency, the association is concerned that patients will...
NHIA seeks permanent payment for COVID therapy
May 26, 2022HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association has sent a letter to Xavier Becerra, secretary of the U.S. Department of Health and Human Service, asking the agency to make permanent Medicare payment for COVID-19 monoclonal antibodies (mABs). HHS’s vaccine program created coverage for home and suite-based infusions of COVID mABs, but it's set to expire when the public health emergency ends. NHIA points out that access to home infusion for mABs for the treatment and prevention...
Soleo Health asks Medicare to expand access to Alzheimer’s treatment
March 17, 2022HME News Staff
FRISCO, Texas – Soleo Health is urging CMS to allow certain monoclonal antibodies to be used in the treatment of Alzheimer’s Disease. “Patient access to innovative therapy treatments is critical to supporting our aging population, including the recent FDA-approved monoclonal antibody treatment for Alzheimer’s patients,” said Drew Walk, CEO. “We believe new therapeutics for those patients in need could prove extremely beneficial to their well-being and quality of...
COVID infusion therapy shifts to the home
October 29, 2021Theresa Flaherty, Managing Editor
YARMOUTH, Maine – The Delta variant of COVID-19 has accelerated demand for monoclonal antibody therapy provided in the home, say home infusion providers, who are stepping up to meet that demand.
“Hospitals don’t have the bandwidth and they don’t want the patients in their settings,” said Greg LoPresti, CEO of Upstate HomeCare in Syracuse, N.Y. “Their intake process takes a long time compared to us. We’ve taken a lot of the caseloads off hospitals.”
In...
Soleo Health tapped by health system to provide mAb therapy at home
September 21, 2021HME News Staff
FRISCO, Texas – Soleo Health has been selected by Houston Methodist to provide monoclonal antibody therapy (mAb) to COVID-19 patients in their homes. The hospital system is among the nation’s largest providers of mAb therapy and has a partnership with the U.S. Department of Human Services, supported by KPMG LLP, to expand access to the treatment to underserved and disadvantaged patients in the greater Houston area. “By teaming up with Houston Methodist to help patients receive therapy...
Upstate joins NHIA in COVID treatment program
June 2, 2021HME News Staff
SYRACUSE, N.Y. – Upstate HomeCare has partnered with the National Home Infusion Therapy Association to offer monoclonal antibody therapies to patients with mild and moderate COVID-19. The NHIA COVID-19 Home Infusion Therapy (C-HIT) Program hosts an online listing of home infusion providers that have agreed to provide these therapies to eligible individuals in their communities. “Upstate HomeCare is proud to be part of the U.S. health care response to the pandemic in our community,”...
NHIA urges commercial payers to cover COVID-19 treatment
April 7, 2021HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association is urging commercial insurance plans to implement coverage policies for COVID-19 monoclonal antibody therapy used in the home. The association also says CMS’s current administration fee of approximately $310 is insufficient to cover the costs. In a study conducted in February, NHIA determined the cost of providing the therapy is between $584 and $1,746. NHIA encourages payers to work with the home...